Chu, R. S., McCool, T., Greenspan, N. S., Schreiber, J. R., & Harding, C. V. (2000). CpG Oligodeoxynucleotides Act as Adjuvants for Pneumococcal Polysaccharide-Protein Conjugate Vaccines and Enhance Antipolysaccharide Immunoglobulin G2a (IgG2a) and IgG3 Antibodies. American Society for Microbiology.
Citación estilo ChicagoChu, Rose S., Tera McCool, Neil S. Greenspan, John R. Schreiber, and Clifford V. Harding. CpG Oligodeoxynucleotides Act As Adjuvants for Pneumococcal Polysaccharide-Protein Conjugate Vaccines and Enhance Antipolysaccharide Immunoglobulin G2a (IgG2a) and IgG3 Antibodies. American Society for Microbiology, 2000.
Cita MLAChu, Rose S., et al. CpG Oligodeoxynucleotides Act As Adjuvants for Pneumococcal Polysaccharide-Protein Conjugate Vaccines and Enhance Antipolysaccharide Immunoglobulin G2a (IgG2a) and IgG3 Antibodies. American Society for Microbiology, 2000.